Filing Details

Accession Number:
0000874015-11-000033
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-12-20 21:09:31
Reporting Period:
2011-12-16
Filing Date:
2011-12-20
Accepted Time:
2011-12-20 21:09:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874015 Isis Pharmaceuticals Inc ISIS Pharmaceutical Preparations (2834) 330336973
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
897667 T Stanley Crooke C/O Isis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad CA 92010
Chairman, President, Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-12-16 15,000 $5.80 15,000 No 4 M Direct
Common Stock Disposition 2011-12-16 15,000 $6.79 0 No 4 S Direct
Common Stock Acquisiton 2011-12-16 1,500 $5.80 1,500 No 4 M Indirect By wife
Common Stock Disposition 2011-12-16 1,500 $6.79 0 No 4 S Indirect By wife
Common Stock Acquisiton 2011-12-19 1,822 $5.80 1,822 No 4 M Direct
Common Stock Disposition 2011-12-19 1,822 $6.90 0 No 4 S Direct
Common Stock Acquisiton 2011-12-19 15,178 $5.80 15,178 No 4 M Direct
Common Stock Disposition 2011-12-19 15,178 $6.82 0 No 4 S Direct
Common Stock Acquisiton 2011-12-19 118 $5.80 118 No 4 M Indirect By wife
Common Stock Disposition 2011-12-19 118 $6.90 0 No 4 S Indirect By wife
Common Stock Acquisiton 2011-12-19 982 $5.80 982 No 4 M Indirect By wife
Common Stock Disposition 2011-12-19 982 $6.82 0 No 4 S Indirect By wife
Common Stock Acquisiton 2011-12-20 22,000 $5.80 22,000 No 4 M Direct
Common Stock Disposition 2011-12-20 22,000 $6.82 0 No 4 S Direct
Common Stock Acquisiton 2011-12-20 5,000 $5.80 5,000 No 4 M Direct
Common Stock Disposition 2011-12-20 5,000 $6.92 0 No 4 S Direct
Common Stock Acquisiton 2011-12-20 300 $5.80 300 No 4 M Indirect By wife
Common Stock Disposition 2011-12-20 300 $6.92 0 No 4 S Indirect By wife
Common Stock Acquisiton 2011-12-20 1,400 $5.80 1,400 No 4 M Indirect By wife
Common Stock Disposition 2011-12-20 1,400 $6.82 0 No 4 S Indirect By wife
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Indirect By wife
No 4 S Indirect By wife
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Indirect By wife
No 4 S Indirect By wife
No 4 M Indirect By wife
No 4 S Indirect By wife
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Indirect By wife
No 4 S Indirect By wife
No 4 M Indirect By wife
No 4 S Indirect By wife
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2011-12-16 15,000 $0.00 15,000 $5.80
Common Stock Employee Stock Option (right to buy) Disposition 2011-12-16 1,500 $0.00 1,500 $5.80
Common Stock Employee Stock Option (right to buy) Disposition 2011-12-19 17,000 $0.00 17,000 $5.80
Common Stock Employee Stock Option (right to buy) Disposition 2011-12-19 1,100 $0.00 1,100 $5.80
Common Stock Employee Stock Option (right to buy) Disposition 2011-12-20 27,000 $0.00 27,000 $5.80
Common Stock Employee Stock Option (right to buy) Disposition 2011-12-20 1,700 $0.00 1,700 $5.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
60,720 2009-01-03 2012-01-02 No 4 M Direct
3,880 2009-01-03 2012-01-02 No 4 M Indirect
43,720 2009-01-03 2012-01-02 No 4 M Direct
2,780 2009-01-03 2012-01-02 No 4 M Indirect
16,720 2009-01-03 2012-01-02 No 4 M Direct
1,080 2009-01-03 2012-01-02 No 4 M Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 875,391 Indirect By Trust
Footnotes
  1. Acquired as a result of exercising a stock option that was scheduled to expire on 1/2/12. The purchase and sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/3/11.
  2. Acquired as a result of exercising a stock option that was scheduled to expire on 1/2/12. The purchase and sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the wife of the reporting person on 10/3/11.